Assessing the FDA via the Anomaly of Off-Label Drug Prescribing
By Alexander T. Tabarrok
This article appeared in the Summer 2000 issue of The Independent Review.
Most American hospital patients are given drugs not approved by the U.S. Food and Drug Administration for the prescribed use. If off-label prescribing is so widespread and successful, is the FDAs pre-approval process really necessary?
|Other Independent Review articles by Alexander T. Tabarrok|
|Fall 2019||Premature Imitation and Indias Flailing State|
|Fall 2013||The Global Organ Shortage: Economic Causes, Human Consequences, Policy Responses|
|Spring 2007||The Rise, Fall, and Rise Again of Privateers|
|[View All (5)]|